UniProt ID | PCNA_MOUSE | |
---|---|---|
UniProt AC | P17918 | |
Protein Name | Proliferating cell nuclear antigen | |
Gene Name | Pcna | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 261 | |
Subcellular Localization | Nucleus . Colocalizes with CREBBP, EP300 and POLD1 to sites of DNA damage (By similarity). Forms nuclear foci representing sites of ongoing DNA replication and vary in morphology and number during S phase. Together with APEX2, is redistributed in dis | |
Protein Description | Auxiliary protein of DNA polymerase delta and is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways. Acts as a loading platform to recruit DDR proteins that allow completion of DNA replication after DNA damage and promote postreplication repair: Monoubiquitinated PCNA leads to recruitment of translesion (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is involved in error-free pathway and employs recombination mechanisms to synthesize across the lesion (By similarity).. | |
Protein Sequence | MFEARLIQGSILKKVLEALKDLINEACWDVSSGGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVIKMPSGEFARICRDLSHIGDAVVISCAKNGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVHLTFALRYLNFFTKATPLSPTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Acetylation | LIQGSILKKVLEALK HHCHHHHHHHHHHHH | 38.88 | 22826441 | |
14 | Acetylation | IQGSILKKVLEALKD HCHHHHHHHHHHHHH | 48.91 | - | |
54 | Phosphorylation | LVQLTLRSEGFDTYR EEEEEECCCCCCEEE | 45.22 | 25777480 | |
59 | Phosphorylation | LRSEGFDTYRCDRNL ECCCCCCEEECCCCC | 15.59 | 25777480 | |
60 | Phosphorylation | RSEGFDTYRCDRNLA CCCCCCEEECCCCCC | 15.87 | 25777480 | |
73 | Phosphorylation | LAMGVNLTSMSKILK CCCCCCHHHHHHHHH | 19.72 | 25777480 | |
74 | Phosphorylation | AMGVNLTSMSKILKC CCCCCHHHHHHHHHH | 24.99 | 25777480 | |
76 | Phosphorylation | GVNLTSMSKILKCAG CCCHHHHHHHHHHHC | 19.13 | 25777480 | |
77 | Acetylation | VNLTSMSKILKCAGN CCHHHHHHHHHHHCC | 43.34 | 22826441 | |
80 | Ubiquitination | TSMSKILKCAGNEDI HHHHHHHHHHCCCCE | 26.05 | - | |
80 | Acetylation | TSMSKILKCAGNEDI HHHHHHHHHHCCCCE | 26.05 | 23806337 | |
80 | Malonylation | TSMSKILKCAGNEDI HHHHHHHHHHCCCCE | 26.05 | 26320211 | |
81 | S-nitrosylation | SMSKILKCAGNEDII HHHHHHHHHCCCCEE | 5.41 | 20925432 | |
81 | Glutathionylation | SMSKILKCAGNEDII HHHHHHHHHCCCCEE | 5.41 | 24333276 | |
81 | S-nitrosocysteine | SMSKILKCAGNEDII HHHHHHHHHCCCCEE | 5.41 | - | |
114 | Phosphorylation | NQEKVSDYEMKLMDL CCCCCCCHHEEECCC | 15.49 | - | |
117 | Ubiquitination | KVSDYEMKLMDLDVE CCCCHHEEECCCCHH | 28.81 | - | |
135 | S-nitrosylation | IPEQEYSCVIKMPSG CCCCEEEEEEECCCC | 3.43 | 19483679 | |
135 | Glutathionylation | IPEQEYSCVIKMPSG CCCCEEEEEEECCCC | 3.43 | 24333276 | |
135 | S-nitrosocysteine | IPEQEYSCVIKMPSG CCCCEEEEEEECCCC | 3.43 | - | |
162 | S-nitrosylation | GDAVVISCAKNGVKF CCEEEEEEECCCCEE | 4.25 | 19483679 | |
162 | Glutathionylation | GDAVVISCAKNGVKF CCEEEEEEECCCCEE | 4.25 | 24333276 | |
162 | S-nitrosocysteine | GDAVVISCAKNGVKF CCEEEEEEECCCCEE | 4.25 | - | |
164 | Ubiquitination | AVVISCAKNGVKFSA EEEEEEECCCCEEEE | 59.57 | 22790023 | |
168 | Ubiquitination | SCAKNGVKFSASGEL EEECCCCEEEECCCC | 34.69 | - | |
211 | Phosphorylation | HLTFALRYLNFFTKA HHHHHHHHHHCCCCC | 13.57 | 17115032 | |
216 | Phosphorylation | LRYLNFFTKATPLSP HHHHHCCCCCCCCCC | 18.68 | 22006019 | |
217 | Ubiquitination | RYLNFFTKATPLSPT HHHHCCCCCCCCCCE | 45.14 | - | |
248 | Ubiquitination | IADMGHLKYYLAPKI ECCCCCCEEEECCCC | 26.61 | - | |
248 | Acetylation | IADMGHLKYYLAPKI ECCCCCCEEEECCCC | 26.61 | 23806337 | |
248 | Succinylation | IADMGHLKYYLAPKI ECCCCCCEEEECCCC | 26.61 | 23806337 | |
254 | Ubiquitination | LKYYLAPKIEDEEAS CEEEECCCCCCCCCC | 53.79 | - | |
254 | Acetylation | LKYYLAPKIEDEEAS CEEEECCCCCCCCCC | 53.79 | 22826441 | |
261 | Phosphorylation | KIEDEEAS------- CCCCCCCC------- | 43.99 | 23984901 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
211 | Y | Phosphorylation | Kinase | EGFR | Q01279 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | Paxip1 | Q6NZQ4 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | Rad18 | Q9QXK2 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
13 | K | Acetylation |
| - |
14 | K | Acetylation |
| - |
63 | K | ubiquitylation |
| - |
77 | K | Acetylation |
| - |
80 | K | Acetylation |
| - |
164 | K | ubiquitylation |
| - |
164 | K | ubiquitylation |
| - |
164 | K | ubiquitylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PCNA_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Tyrosine phosphorylation controls PCNA function through proteinstability."; Wang S.C., Nakajima Y., Yu Y.L., Xia W., Chen C.T., Yang C.C.,McIntush E.W., Li L.Y., Hawke D.H., Kobayashi R., Hung M.C.; Nat. Cell Biol. 8:1359-1368(2006). Cited for: PHOSPHORYLATION AT TYR-211. |